The trademark application GV20 was filed by Shanghai Xunbaihui Biotechnology Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 30, 2021, and it was registered by office on January 7, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Pharmaceutical preparations for the treatment of cancer
Pharmaceutical preparations for the treatment of genetic diseases.
The mark was filed in class 42 with following description of goods:
Conducting early evaluations in the field of new pharmaceuticals
Research and development of pharmaceutical and biopharmaceutical preparations and medicines
Pharmaceutical and biotechnology products development
Research and development in the pharmaceutical and biotechnology fields
Pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases
Pharmaceutical and biopharmaceutical research services in the nature of biomarker identification
Pharmaceutical and biopharmaceutical research services, namely artificial intelligence assisted drug discovery and development services
Software as a service services for artificial intelligence software for drug discovery and development.